BMUS: The Burden of Musculoskeletal Diseases in the United States
Published on BMUS: The Burden of Musculoskeletal Diseases in the United States (https://bmus.latticegroup.com)

Home > Topics > The Big Picture > Health Care Utilization and Economic Cost

Health Care Utilization and Economic Cost

I.F.0
Musculoskeletal Diseases

Lead Author(s): 

Stuart I. Weinstein, MD
Edward H. Yelin, PhD

Supporting Author(s): 

Sylvia I. Watkins-Castillo, PhD
The annual average proportion of the US population with a musculoskeletal condition requiring medical care has increased by more than five percentage points over the past decade and now constitutes more than 33% of the population. This is an overall rate of increase of 19%. The majority of growth in both the proportion of the population, and in the number of people, with a musculoskeletal condition is in the 45 to 64-year age bracket, with persons age 65 years and older with musculoskeletal conditions also rising. (Reference Table 10.1 PDF [1] CSV [2] and Table 10.1.1 PDF [3] CSV [4])
Number of Persons with Musculoskeletal Diseases by Age, United States 1996-1998 and 2009-2011
The annual estimated direct and indirect cost attributable to persons with a musculoskeletal disease is $213 billion. Taking into account all costs for persons with a musculoskeletal disease including other comorbid conditions, the cost of treating these individuals and the cost to society in the form of decreased wages is estimated to currently be nearly $874 billion per year. Over the last 15 years, costs associated with musculoskeletal conditions have risen from 3.43% of the GDP to 5.73%.  (Reference Table 10.10 PDF [5] CSV [6] and Table 10.14 PDF [7] CSV [8])
Total Direct and Indirect (Earnings Losses) Costs of Musculoskeletal Conditions as a Proportion of Gross Domestic Product (GDP) in 2011 $s, United States 1996-2011
Treatments that mitigate the long-term impacts of musculoskeletal conditions and return persons to full and active lives are needed.

Edition: 

  • 2014

Direct Costs

I.F.1

Lead Author(s): 

Stuart I. Weinstein, MD
Edward H. Yelin, PhD

Supporting Author(s): 

Sylvia I. Watkins-Castillo, PhD

The increasing prevalence of musculoskeletal conditions, along with a growing and aging population, has resulted in more than a 50% increase in total aggregate direct cost to treat persons with a musculoskeletal condition over the past decade, in constant 2011 dollars. For the years between 2009 and 2011, the annual average direct cost in 2011 dollars for musculoskeletal health care—both as a direct result of a musculoskeletal disease and for patients with a musculoskeletal disease in addition to other health issues—is estimated to be $796.3 billion, the equivalent of 5.2% of the national gross domestic product (GDP).

Total medical care costs are the costs for all of an individual’s conditions, including musculoskeletal conditions. Incremental medical care costs are that part of total medical care costs attributable solely to the musculoskeletal conditions. Incremental medical costs for musculoskeletal conditions for the years between 2009 and 2011 are estimated to be $212.7 billion, in 2011 dollars. (Reference Table 10.6 PDF [9] CSV [10], and Table 10.14 PDF [7] CSV [8])

Edition: 

  • 2014

Indirect Costs

I.F.2

Lead Author(s): 

Stuart I. Weinstein, MD
Edward H. Yelin, PhD

Supporting Author(s): 

Sylvia I. Watkins-Castillo, PhD

Indirect costs measure disease impact in terms of lost wages due to disability or death.  Indirect costs, like medical care costs, can be estimated and calculated in total for all the medical conditions an individual has, and as the increment attributable solely to musculoskeletal conditions.

Indirect cost for persons age 18 to 64 with a work history add another $77.5 billion, or 0.5% of the GDP in between 2009 and 2011, to the cost for all persons with a musculoskeletal disease, either treated as a primary condition or in addition to another condition. Annual indirect costs attributable to musculoskeletal disease alone (incremental cost) account for an estimated $130.7 billion. Indirect costs attributable to musculoskeletal disease are greater than total indirect costs because of a 4% gap in the probability of working between persons with and without a musculoskeletal condition and a lower mean income. (Reference Table 10.12 PDF [11] CSV [12])

Edition: 

  • 2014
The Burden of Musculoskeletal Diseases in the United States - Copyright © 2014.

Source URL: https://bmus.latticegroup.com/2014-report/if0/health-care-utilization-and-economic-cost

Links:
[1] https://bmus.latticegroup.com/docs/T10001.1.pdf
[2] https://bmus.latticegroup.com/docs/T10001.1.csv
[3] https://bmus.latticegroup.com/docs/T10002.1.1.pdf
[4] https://bmus.latticegroup.com/docs/T10002.1.1.csv
[5] https://bmus.latticegroup.com/docs/T10011.10.pdf
[6] https://bmus.latticegroup.com/docs/T10011.10.csv
[7] https://bmus.latticegroup.com/docs/T10015.14.pdf
[8] https://bmus.latticegroup.com/docs/T10015.14.csv
[9] https://bmus.latticegroup.com/docs/T10007.6.pdf
[10] https://bmus.latticegroup.com/docs/T10007.6.csv
[11] https://bmus.latticegroup.com/docs/T10013.12.pdf
[12] https://bmus.latticegroup.com/docs/T10013.12.csv